/Companies

ArkeaBio

4 known investors

Find your way into ArkeaBio

410 people in our graph share verified history with the ArkeaBio team — schools, employers, funds. One of them is your warm intro.

Curt Robertsunlockedknows Frank Wooten · together at Vence, Corp. (overlapped)
×4knows the team · via ArkeaBio
×7knows the team · via Zymergen

ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.

Founders & leadership

FWFrank Wooten
Frank WootenChief Executive OfficerCEO of ArkeaBio, which develops a methane-reducing vaccine for cattle to lower agricultural emissions.
ZSZach Serber
Zach SerberChief Technology Officer
CSColin South
Colin SouthChief Business OfficerHe has held executive and technology leadership roles across food, life sciences, and energy sectors, with background in engineering and science combined with business strategy and commercialization expertise.

Investors · 4

Funding

SEC filings, press & company announcements

$26.5M disclosed across 1 of 4 rounds · 2022–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does ArkeaBio do?
ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
Who are ArkeaBio's investors?
ArkeaBio's investors include Breakthrough Energy Ventures, NYA Ventures, Rabo Corporate Venturing, AgriZeroNZ.
How much funding has ArkeaBio raised?
ArkeaBio has disclosed $26.5M raised across 1 of its 4 known rounds.